First CAR T cell therapy targeting BAFF-R eradicates blood cancers that relapsed after CD19 CAR T therapies | City of Hope | Vectorology - GEG Tech top picks | Scoop.it

CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies